Targeting the bradykinin B1 receptor to reduce pain

Bibliography

• MARCEAU F, REGOLI D: Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. (2004) 3(10):845-852.
   Google Scholar
• MARCEAU F: Kinin B1 receptors: a review. Immunopharmacology (1995) 30(1):1-26.
   PubMed Web of Science ®Google Scholar
• CALIXTO JB, CABRINI DA, FERREIRA J, CAMPOS MM: Inflammatory pain: kinins and antagonists. Curr. Opin. Anaesthesiol. (2001) 14:519-526.
   PubMedGoogle Scholar
• CALIXTO JB, MEDEIROS R, FERNANDES ES et al.: Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. (2004) 143(7):803-818.
   PubMed Web of Science ®Google Scholar
• DRAY A: Kinins and their receptors in hyperalgesia. Can. J. Physiol. Pharmacol. (1997) 75(6):704-712.
   PubMed Web of Science ®Google Scholar
• DAVIS AJ, KELLY D, PERKINS MN: The induction of des-Arg9-bradykinin-mediated hyperalgesia in the rat by inflammatory stimuli. Braz. J. Med. Biol. Res. (1994) 27(8):1793-1802.
   Google Scholar
• PERKINS MN, KELLY D: Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol. (1993) 110(4):1441-1444.
   Google Scholar
• RASHID MH, INOUE M, MATSUMOTO M, UEDA H: Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J. Pharmacol. Exp.Ther. (2004) 308(3):1158-1164.
   Google Scholar
• MARCEAU F, HESS JF, BACHVAROV DR: The B-1 receptors for kinins. Pharmacol. Rev. (1998) 50(3):357-386.
   PubMed Web of Science ®Google Scholar
• MARCEAU F, SABOURIN T, HOULE S et al.: Kinin receptors: functional aspects. Int. Immunopharmacol. (2002) 2(13-14):1729-1739.
   PubMed Web of Science ®Google Scholar
• PASSOS GF, FERNANDES ES, CAMPOS MM et al.: Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx. J. Immunol. (2004) 172(3):1839-1847.
   PubMed Web of Science ®Google Scholar
• CAMPOS MM, DE SOUZA GE, RICCI ND et al.: The role of migrating leukocytes in IL-1 beta-induced up-regulation of kinin B(1) receptors in rats. Br. J. Pharmacol. (2002) 135(5):1107-1114.
   Google Scholar
• AHLUWALIA A, PERRETTI M: B1 receptors as a new inflammatory target. Could this B the 1? Trends Pharmacol. Sci. (1999) 20(3):100-104.
   PubMedGoogle Scholar
• BOCKMANN S, PAEGELOW I: Kinins and kinin receptors: importance for the activation of leukocytes. J. Leukoc. Biol. (2000) 68(5):587-592.
   PubMed Web of Science ®Google Scholar
• PHAGOO SB, YAQOOB M, HERRERA-MARTINEZ E et al.: Regulation of bradykinin receptor gene expression in human lung fibroblasts. Eur. J. Pharmacol. (2000) 397(2-3):237-246.
   PubMed Web of Science ®Google Scholar
• SEABROOK GR, BOWERY BJ, HEAVENS R et al.: Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice. Neuropharmacology (1997) 36(7):1009-1017.
   Google Scholar
• TSUKAGOSHI H, SHIMIZU Y, HORIE T et al.: Regulation by interleukin-1beta of gene expression of bradykinin B1 receptor in MH-S murine alveolar macrophage cell line. Biochem. Biophys. Res. Commun. (1999) 259(2):476-482.
   Google Scholar
• FERNANDES ES, PASSOS GF, CAMPOS MM et al.: Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw. Br. J. Pharmacol. (2003) 139(5):973-981.
   PubMedGoogle Scholar
• LEVESQUE L, DRAPEAU G, GROSE JH, RIOUX F, MARCEAU F: Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Br. J. Pharmacol. (1993) 109(4):1254-1262.
   Google Scholar
• MCLEAN PG, AHLUWALIA A, PERRETTI M: Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules. J. Exp. Med. (2000) 192(3):367-380.
   PubMed Web of Science ®Google Scholar
• PESQUERO JB, ARAUJO RC, HEPPENSTALL PA et al.: Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Natl. Acad. Sci. USA (2000) 97(14):8140-8145.
   PubMed Web of Science ®Google Scholar
• VIANNA RM, CALIXTO JB: Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Br. J. Pharmacol. (1998) 123(2):281-291.
   Google Scholar
• ARAUJO RC, KETTRITZ R, FICHTNER I et al.: Altered neutrophil homeostasis in kinin B1 receptor-deficient mice. Biol. Chem. (2001) 382(1):91-95.
   Google Scholar
• EHRENFELD P, MILLAN C, MATUS CE et al.: Activation of kinin B1 receptors induces chemotaxis of human neutrophils. J. Leukoc. Biol. (2006) 80(1):117-124.
   PubMed Web of Science ®Google Scholar
• VELLANI V, ZACHRISSON O, MCNAUGHTON PA: Functional bradykinin B1 receptors are expressed in nociceptive neurones and are upregulated by the neurotrophin GDNF. J. Physiol (2004) 560(Pt 2):391-401.
   PubMed Web of Science ®Google Scholar
• WOTHERSPOON G, WINTER J: Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system. Neurosci. Lett. (2000) 294(3):175-178.
   PubMed Web of Science ®Google Scholar
• DRAY A, PERKINS M: Bradykinin and inflammatory pain. Trends Neurosci. (1993) 16(3):99-104.
   PubMed Web of Science ®Google Scholar
• FERREIRA SH, LORENZETTI BB, POOLE S: Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. (1993) 110(3):1227-1231.
   PubMed Web of Science ®Google Scholar
• FERREIRA J, CAMPOS MM, PESQUERO JB et al.: Evidence for the participation of kinins in Freund’s adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. Neuropharmacology (2001) 41(8):1006-1012.
   Google Scholar
• DUKA A, DUKA I, GAO G et al.: Role of bradykinin B1 and B2 receptors in normal blood pressure regulation. Am. J. Physiol. Endocrinol. Metab. (2006) 291(2):E268-E274.
   PubMed Web of Science ®Google Scholar
• ALFIE ME, SIGMON DH, POMPOSIELLO SI, CARRETERO OA: Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension (1997) 29(1 Pt 2):483-487.
   PubMed Web of Science ®Google Scholar
• BORKOWSKI JA, RANSOM RW, SEABROOK GR et al.: Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem. (1995) 270(23):13706-13710.
   PubMedGoogle Scholar
• PERKINS MN, CAMPBELL E, DRAY A: Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain (1993) 53(2):191-197.
   PubMed Web of Science ®Google Scholar
• CAMPOS MM, MATA LV, CALIXTO JB: Expression of B1 kinin receptors mediating paw edema and formalin-induced nociception. Modulation by glucocorticoids. Can. J. Physiol. Pharmacol. (1995) 73(7):812-819.
   Google Scholar
• CORREA CR, CALIXTO JB: Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol. (1993) 110(1):193-198.
   PubMed Web of Science ®Google Scholar
• DAVIS AJ, PERKINS MN: Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat. Neuropharmacology (1994) 33(1):127-133.
   Google Scholar
• DAVIS AJ, PERKINS MN: Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors. Br. J. Pharmacol. (1996) 118(8):2206-2212.
   Google Scholar
• LEVY D, ZOCHODNE DW: Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain (2000) 86(3):265-271.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI-SASE S, HAYASHI I, OKAMOTO H et al.: Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats. Inflamm. Res. (2003) 52(4):164-169.
   Google Scholar
• GABRA BH, SIROIS P: Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides (2003) 24(8):1131-1139.
   PubMed Web of Science ®Google Scholar
• GABRA BH, SIROIS P: Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice. Neuropeptides (2003) 37(1):36-44.
   Google Scholar
• PRAT A, WEINRIB L, BECHER B et al.: Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology (1999) 53(9):2087-.
   PubMed Web of Science ®Google Scholar
• TSCHOPE C, SPILLMANN F, ALTMANN C et al.: The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc. Res. (2004) 61(3):559-569.
   Google Scholar
• XU J, CARRETERO OA, SUN Y et al.: Role of the B1 kinin receptor in the regulation of cardiac function and Remodeling after myocardial infarction. Hypertension (2005) 45(4):747-753.
   PubMedGoogle Scholar
• AGATA J, MIAO RQ, YAYAMA K, CHAO L, CHAO J: Bradykinin B1 receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension (2000) 36(3):364-370.
   PubMed Web of Science ®Google Scholar
• HESS JF, BORKOWSKI JA, STONESIFER GY et al.: Cloning and pharmacological characterization of bradykinin receptors. Braz. J. Med. Biol. Res. (1994) 27(8):1725-1731.
   Google Scholar
• DUPRIEZ VJ, MAES K, LE PE et al.: Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors. Receptors Channels (2002) 8(5-6):319-330.
   PubMedGoogle Scholar
• GEORGE SE, SCHAEFFER MT, CULLY D et al.: A high-throughput glow-type aequorin assay for measuring receptor-mediated changes in intracellular calcium levels. Anal. Biochem. (2000) 286(2):231-237.
   Google Scholar
• HOOK DJ: Case study of the automation options and decisions made in implementing a high-throughput cell based screen using the FLIPR (TM). J. Automated Methods Manage. Chem. (2000) 22(5):139-142.
   Google Scholar
• LE PE, HISADA S, MIZUGUCHI Y et al.: Adaptation of aequorin functional assay to high throughput screening. J. Biomol. Screening (2002) 7(1):57-65.
   Google Scholar
• RAZVI EP: Trends and bottlenecks in G protein-coupled receptor screening. Drug Market Dev. (2003) 14(9):283-287.
   Google Scholar
• UNGRIN MD, SINGH LM, STOCCO R et al.: An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors. Analytical Biochem. (1999) 272(1):34-42.
   PubMed Web of Science ®Google Scholar
• FOTSCH C, BIDDLECOME G, BISWAS K et al.: A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core. Bioorg. Med. Chem. Lett. (2006) 16(8):2071-2075.
   Google Scholar
• GOBEIL F, PHENG LH, BADINI I et al.: Receptors for kinins in the human isolated umbilical vein. Br. J. Pharmacol. (1996) 118(2):289-294.
   PubMedGoogle Scholar
• HESS JF, HEY PJ, CHEN TB et al.: Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors. Biol. Chem. (2001) 382(1):123-129.
   Google Scholar
• HESS JF, HEY PJ, CHEN TB et al.: Molecular and pharmacological diversity of the kinin B1 receptor. Int. Immunopharmacol. (2002) 2(13-14):1747-1754.
   PubMed Web of Science ®Google Scholar
• JONES C, PHILLIPS E, DAVIS C et al.: Molecular characterization of cloned bradykinin B1 receptors from rat and human. Eur. J. Pharmacol. (1999) 374(3):423-433.
   Google Scholar
• FOX A, KAUR S, LI BF et al.: Antihyperalgesic activity of a novel nonpeptide bradykinin B-1 receptor antagonist in transgenic mice expressing the human B-1 receptor. Br. J. Pharmacol. (2005) 144(7):889-899.
   PubMed Web of Science ®Google Scholar
• HESS JF, CHEN RZ, HEY P et al.: Generation and characterization of a humanized bradykinin B1 receptor mouse. Biol. Chem. (2006) 387(2):195-201.
   Google Scholar
• KUDUK SD, NG C, FENG D-M et al.: 2,3-diaminopyridine bradykinin B1 receptor antagonists. J. Med. Chem. (2004) 47(26):6439-6442.
   Google Scholar
• MASON GS: The bradykinin B1 receptor antagonist B9858 inhibits a nociceptive spinal reflex in rabbits. Can. J. Physiol. Pharmacol. (2002) 80(4):264-268
   Google Scholar
• MORISSETTE G, FORTIN J-P, OTIS S, BOUTHILLIER J, MARCEAU F: A novel nonpeptide antagonist of the kinin B1 receptor: Effects at the rabbit receptor. J. Pharmacol. Exp. Ther. (2004) 311(3):1121-1130.
   Google Scholar
• MANNING B, DONG H, MAGAL E, JOHNSON E: Inflammatory pain in conscious rabbits: a new, efficient method for measuring mechanical hyperalgesia in the hind paw. 11th World Congress on Pain (2005).
   Google Scholar
• MCLEAN PG, PERRETTI M, AHLUWALIA A: Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des-Arg9bradykinin-induced coronary vasodilation. Br. J. Pharmacol. (1999) 128(2):275-282.
   PubMed Web of Science ®Google Scholar
• MCLEAN PG, PERRETTI M, AHLUWALIA A: Kinin B(1) receptors and the cardiovascular system: regulation of expression and function. Cardiovasc. Res. (2000) 48(2):194-210.
   PubMed Web of Science ®Google Scholar
• NEUGEBAUER W, BLAIS PA, HALLE S et al.: Kinin B1 receptor antagonists with multi-enzymatic resistance properties. Can. J. Physiol. Pharmacol. (2002) 80(4):287-292.
   PubMedGoogle Scholar
• BOCK MG, HESS JF, PETTIBONE DJ: Bradykinin-1 receptor antagonists. Ann. Rep. Med. Chem. (2003) 38:111-120.
   Google Scholar
• GOUGAT J, FERRARI B, SARRAN L et al.: SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3- {[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4- {[2R,6s)-2,6-dimethylpiperidinyl]methyl}phenyl)-N -isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: Biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther. (2004) 309(2):661-669.
   PubMed Web of Science ®Google Scholar
• PORRECA F, VANDERAH TW, GUO W et al.: Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist. J. Pharmacol. Exp. Ther. (2006) 318(1):195-205.
   PubMed Web of Science ®Google Scholar
• SU D-S, MARKOWITZ MK, DIPARDO RM et al.: Discovery of a potent, non-peptide bradykinin B1 receptor antagonist. J. Am. Chem. Soc. (2003) 125(25):7516-7517.
   PubMed Web of Science ®Google Scholar
• HA SN, HEY PJ, RANSOM RW et al.: Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1. Biochem. Biophys. Res. Comm. (2005) 331(1):159-166.
   Google Scholar
• RITCHIE TJ, DZIADULEWICZ EK, CULSHAW AJ et al.: Potent and orally bioavailable non-peptide antagonists at the human bradykinin B1 receptor based on a 2-alkylamino-5-sulfamoylbenzamide core. J. Med. Chem. (2004) 47(19):4642-4644.
   PubMed Web of Science ®Google Scholar
• HORLICK RA, OHLMEYER MH, STROKE IL et al.: Small molecule antagonists of the bradykinin B1 receptor. Immunopharmacology (1999) 43(2-3):169-177.
   PubMed Web of Science ®Google Scholar
• WOOD MR, KIM JJ, HAN W et al.: Benzodiazepines as potent and selective bradykinin B1 antagonists. J. Med. Chem. (2003) 46(10):1803-1806.
   Google Scholar
• KUDUK SD, CHANG RK, NG C et al.: Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series. Bioorg. Med. Chem. Lett. (2005) 15(17):3925-3929.
   PubMed Web of Science ®Google Scholar
• FENG D-M, WAI JM, KUDUK SD et al.: 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists. Bioorg. Med. Chem. Lett. (2005) 15(9):2385-2388.
   PubMed Web of Science ®Google Scholar
• TANG C, SUBRAMANIAN R, KUO Y et al.: Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates. Chem. Res. Toxicol. (2005) 18(6):934-945.
   PubMed Web of Science ®Google Scholar
• WOOD MR, SCHIRRIPA KM, KIM JJ et al.: Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists. J. Med. Chem. (2006) 49(4):1231-1234.
   PubMed Web of Science ®Google Scholar
• KUDUK SD, DI MARCO CN, CHANG RK et al.: 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists. Bioorg. Med. Chem. Lett. (2006) 16(10):2791-2795.
   PubMed Web of Science ®Google Scholar